These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33936456)

  • 1. Identification of Common Data Elements from Pivotal FDA Trials.
    Mayer CS; Williams N; Huser V
    AMIA Annu Symp Proc; 2020; 2020():813-822. PubMed ID: 33936456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.
    Downing NS; Aminawung JA; Shah ND; Krumholz HM; Ross JS
    JAMA; 2014 Jan 22-29; 311(4):368-77. PubMed ID: 24449315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies.
    Ladanie A; Speich B; Briel M; Sclafani F; Bucher HC; Agarwal A; Ioannidis JPA; Pereira TV; Kasenda B; Hemkens LG
    J Clin Epidemiol; 2019 Oct; 114():49-59. PubMed ID: 31158450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016.
    Ladanie A; Schmitt AM; Speich B; Naudet F; Agarwal A; Pereira TV; Sclafani F; Herbrand AK; Briel M; Martin-Liberal J; Schmid T; Ewald H; Ioannidis JPA; Bucher HC; Kasenda B; Hemkens LG
    JAMA Netw Open; 2020 Nov; 3(11):e2024406. PubMed ID: 33170262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of pivotal clinical trial results reporting for newly approved medications varied by reporting source.
    Withycombe B; Ovenell M; Meeker A; Ahmed SM; Hartung DM
    J Clin Epidemiol; 2016 Sep; 77():78-83. PubMed ID: 27108488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study.
    Wallach JD; Ciani O; Pease AM; Gonsalves GS; Krumholz HM; Taylor RS; Ross JS
    BMC Med; 2018 Mar; 16(1):45. PubMed ID: 29562926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of orphan drug applications that fail to achieve marketing approval in the USA.
    Heemstra HE; Leufkens HG; Rodgers RP; Xu K; Voordouw BC; Braun MM
    Drug Discov Today; 2011 Jan; 16(1-2):73-80. PubMed ID: 21094692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Publication of clinical trials supporting successful new drug applications: a literature analysis.
    Lee K; Bacchetti P; Sim I
    PLoS Med; 2008 Sep; 5(9):e191. PubMed ID: 18816163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US Food and Drug Administration Approval of Drugs Not Meeting Pivotal Trial Primary End Points, 2018-2021.
    Johnston JL; Ross JS; Ramachandran R
    JAMA Intern Med; 2023 Apr; 183(4):376-380. PubMed ID: 36780148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.
    Moore TJ; Zhang H; Anderson G; Alexander GC
    JAMA Intern Med; 2018 Nov; 178(11):1451-1457. PubMed ID: 30264133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
    Downing NS; Shah ND; Neiman JH; Aminawung JA; Krumholz HM; Ross JS
    Trials; 2016 Apr; 17():199. PubMed ID: 27079511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US Food and Drug Administration Recommendations on the Use of Surrogate Measures as End Points in New Anti-infective Drug Approvals.
    Hey SP; Kesselheim AS; Patel P; Mehrotra P; Powers JH
    JAMA Intern Med; 2020 Jan; 180(1):131-138. PubMed ID: 31710344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review.
    Pease AM; Krumholz HM; Downing NS; Aminawung JA; Shah ND; Ross JS
    BMJ; 2017 May; 357():j1680. PubMed ID: 28468750
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014.
    Rathi VK; Wang B; Ross JS; Downing NS; Kesselheim AS; Gray ST
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):683-692. PubMed ID: 28116974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
    Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
    Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographics of clinical trials participants in pivotal clinical trials for new molecular entity drugs and biologics approved by FDA From 2010 to 2012.
    Eshera N; Itana H; Zhang L; Soon G; Fadiran EO
    Am J Ther; 2015; 22(6):435-55. PubMed ID: 25621972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.
    Schwartz LM; Woloshin S; Zheng E; Tse T; Zarin DA
    Ann Intern Med; 2016 Sep; 165(6):421-30. PubMed ID: 27294570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis.
    Wallach JD; Luxkaranayagam AT; Dhruva SS; Miller JE; Ross JS
    BMC Med; 2019 Jun; 17(1):117. PubMed ID: 31203816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of clinical trial settings of drugs commonly used in primary care and approved between 2005 and 2012.
    Crossley JR; Tan TP; Smith KH; Ross JS; Merenstein DJ
    J Gen Intern Med; 2018 Sep; 33(9):1431-1432. PubMed ID: 29777429
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA: evidentiary standards for drug development and approval.
    Katz R
    NeuroRx; 2004 Jul; 1(3):307-16. PubMed ID: 15717032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.